Home  >  News
Msc_Apr23 .
you can get e-magazine links on WhatsApp. Click here
  Strides receives US FDA approval for icosapent ethyl capsules,   September 25, 2023
  Lupin buys five brands in gastroenterology, urology & anti-infectives from Menarini,   September 22, 2023
  Alkem Labs brands its API business as Alkem Activa,   September 22, 2023
  Glenmark Pharma to divest majority stake in Glenmark Life Sciences to Nirma Limited for Rs. 56,515 million,   September 22, 2023
  Strides receives tentative US FDA approval for dolutegravir/ lamivudine/tenofovir disproxil fumurate tablets,   September 20, 2023
  US generic sales of Indian pharma majors expected to see 13% CAGR over FY 2023-25: Motilal Oswal report,   September 18, 2023
  India’s largest excipient plant set up by Nitika Pharma in Nagpur under PLI scheme to boost both domestic industry and export markets: Devendra Fadnavis,   September 18, 2023
  Cabinet approves foreign investment of up to Rs.9,589 crore in Suven Pharmaceuticals,   September 13, 2023
  Gaurav Burman of Dabur acquires strategic stake in health start-up Mitsu,   September 13, 2023
  Universal-Halwasiya Group makes Rs. 113 crore open offer to acquire 26% in condom maker Cupid,   September 13, 2023
  IndiaRF announces Rs. 525 crore investment in Ivy Health and Life Sciences,   September 12, 2023
  JB Pharma publishes its 2nd Sustainability (ESG) Report for FY 2022-23,   September 12, 2023
  Indian pharma sector to witness 8-10% revenue growth in fiscal 2024: CRISIL,   September 11, 2023
  Strides receives US FDA approval for sevelamer carbonate for oral suspension,   September 11, 2023
  Morgan Stanley acquires majority stake in ClearMedi Healthcare, appoints Navneet Bali as ClearMedi CEO,   September 07, 2023
  Viatris gets US FDA tentative nod for a paediatric formulation of abacavir a once-daily for HIV children,   September 05, 2023
  DIPAM releases IPM and EoI to disinvest entire stake in IMPCL,   September 05, 2023
  LISSUN raises $1.3 million in seed round led by Inflection Point Ventures & Nithin Kamath backed Rainmatter,   September 04, 2023
  Biocon Generics acquires Eywa Pharma’s oral solid dosage manufacturing facility in New Jersey for US$ 7.7 million,   September 02, 2023
  MediBuddy secures $18 million funding to drive strategic acquisitions and continued expansion,   August 31, 2023

Pharma live expo
Copyright © 2023 Saffron Media Pvt. Ltd |